Board of Directors

Mr. Vanderbruggen is founder and Managing Director of Leeward Ventures SICAR, a Luxembourg private equity fund with more than 80 million euro in assets under management.

Mr. Hopkins is a partner and co-founder of HLL Partners, an investment firm focused on high value-added manufacturing companies in China. Prior to forming HLL Partners, Mr. Hopkins co-founded J.W. Childs Associates, a U.S. middle market private equity firm, where he was a partner in the firm, a member of the investment committee, and president of Asian operations. Mr. Hopkins holds B.S. and M.S. degrees in electrical engineering from the Massachusetts Institute of Technology.

Mr. De Backer joined RHEI Pharmaceuticals in November 2007 and has more than 15 years of experience in finance & general management. Prior to joining RHEI, Mr. De Backer worked for three years as an independent consultant providing interim management and strategic consultancy services to high tech start-up companies and spin-offs. Mr. De Backer started his career as Investment Manager at Lessius, a private Belgian investment banker. Between 1997 and 2005 Mr. De Backer served at Spector Photo Group, an independent photographic company where he held several positions as Group Financial Controller, Finance & Administration Manager and Business Unit Manager in Belgium, the Netherlands and France. Mr. De Backer holds an MBA in Finance at the Vlerick Leuven Ghent Management School.

Madame Zheng graduated from mechanical engineering department of Beijing University of Technology in 1969 and from postgraduate class of Central Party School in 1985. She started her career in 1969 and used to be the deputy director of Shaanxi Pharmaceutical Administration Bureau, Chairman of Xian-Janssen Pharmaceutical Ltd., General Manager of Shaanxi Pharmaceutical Group Corporation and Chairman of China National Pharmaceutical Group Corporation. Mme Zheng is currently Chairman of the China Pharmaceutical Industry Association.